Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
SURGERY PARTNERS, INC. |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 31.98 USD | -1.54% | -2.35% | +14.79% | |
| Dec. 06 | Surgery Partners Unit Receives Commitments for New $1.4 Billion Term Loan | MT |
| Nov. 15 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
| Sales 2023 * | 2.75B | Sales 2024 * | 2.99B | Capitalization | 4.08B |
|---|---|---|---|---|---|
| Net income 2023 * | 38M | Net income 2024 * | 103M | EV / Sales 2023 * | 2,39x |
| Net Debt 2023 * | 2.48B | Net Debt 2024 * | 2.56B | EV / Sales 2024 * | 2,22x |
| P/E ratio 2023 * | 153x | P/E ratio 2024 * | 45,3x | Employees | 10,650 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 52.73% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | -1.22% | ||
| 1 week | -0.82% | ||
| Current month | -0.82% | ||
| 1 month | +14.85% | ||
| 3 months | -0.06% | ||
| 6 months | -16.07% | ||
| Current year | +16.58% |
1 week
31.85
35.64
1 month
25.1635.64
Current year
22.0545.79
1 year
22.0545.79
3 years
20.4669.58
5 years
4.0069.58
10 years
4.0069.58
| Managers | Title | Age | Since |
|---|---|---|---|
J. Evans
CEO | Chief Executive Officer | 46 | 2019 |
David Doherty
DFI | Director of Finance/CFO | 50 | 2018 |
Wayne DeVeydt
CHM | Chairman | 53 | 2018 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Clifford Adlerz
BRD | Director/Board Member | 69 | 2017 |
| Director/Board Member | 57 | 2015 | |
Wayne DeVeydt
CHM | Chairman | 53 | 2018 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.86% | 80 M€ | +1.13% | ||
| 1.25% | 5 M€ | -1.80% | - | |
| 0.53% | 821 M€ | -3.90% | - | |
| 0.29% | 3 M€ | -1.48% | - | |
| 0.25% | 365 M€ | +6.76% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-08 | 31.98 | -1.54% | 787 725 |
| 23-12-07 | 32.48 | -1.22% | 1,226,688 |
| 23-12-06 | 32.88 | -2.78% | 635,353 |
| 23-12-05 | 33.82 | -4.76% | 1,015,103 |
| 23-12-04 | 35.51 | +4.29% | 779,857 |
Delayed Quote Nasdaq, December 07, 2023 at 03:59 pm EST
More quotes
Surgery Partners, Inc., through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through two segments: Surgical Facility Services and Ancillary Services. Its Surgical Facility Services segment includes the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which includes its anesthesia services. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. Its Ancillary Services segment consists of multi-specialty physician practices. The Company has a portfolio of approximately 146 surgical facilities in the United States, which consists of 127 ASCs and 19 surgical hospitals across 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
Calendar
2024-02-26
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
32.48USD
Average target price
43.9USD
Spread / Average Target
+35.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.58% | 4 076 M $ | |
| -33.01% | 20 901 M $ | |
| +9.10% | 17 330 M $ | |
| -11.21% | 11 633 M $ | |
| -6.43% | 10 976 M $ | |
| +23.71% | 9 422 M $ | |
| -24.99% | 7 271 M $ | |
| +8.66% | 6 515 M $ | |
| +10.05% | 6 132 M $ | |
| +12.93% | 5 982 M $ |
